Erytech Pharma SA (NASDAQ:ERYP)

7.60
Delayed Data
As of Jul 10
 0.00 / 0.00%
Today’s Change
3.50
Today|||52-Week Range
12.00
+3.05%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Erytech Pharma SA have a median target of 21.95, with a high estimate of 28.93 and a low estimate of 13.00. The median estimate represents a +188.76% increase from the last price of 7.60.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Erytech Pharma SA. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
$1.1M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually 21.22%
 
 
 
 
 
 

Sales

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually 102.26%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.